Clinical Trial Update: Trimebutine on the Development of Adverse Events Related to the Helicobacter Pylori Eradication Medications [Phase 4]

View source ↗

Summary

Phase 4 trial assessing adverse events related to Helicobacter pylori eradication medications in patients with H. pylori infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• Trimebutine (trimebutine)

Snippet

Sponsor: Chuncheon Sacred Heart Hospital | Conditions: Helicobacter Pylori Infection | Phase 4 | Status: COMPLETED